Katy Barglow

Katy Barglow Email and Phone Number

SVP Technical Operations at 4D Molecular Therapeutics @ 4D Molecular Therapeutics
Katy Barglow's Location
Walnut Creek, California, United States, United States
Katy Barglow's Contact Details
About Katy Barglow

CMC leader in the gene therapy space, leading process development, clinical manufacturing, analytical development, and QC functions. I am currently Sr Vice President, Technical Operations, for 4D Molecular Therapeutics, a novel AAV gene therapy company. I am responsible for driving our "IND engine" and CMC strategy (process, analytical, and CMC-quality/regulatory) for pre-clinical and clinical AAV products.Skills: Process development (Biologics and gene therapy vectors), process transfers and CMO management, assay development/qualification/validation, IND-enabling characterization strategy, real-time and accelerated stability studies, QC assay transfers, IND Module 3 and CMC regulatory strategy, OOS and DR investigations.

Katy Barglow's Current Company Details
4D Molecular Therapeutics

4D Molecular Therapeutics

View
SVP Technical Operations at 4D Molecular Therapeutics
Katy Barglow Work Experience Details
  • 4D Molecular Therapeutics
    Senior Vice President
    4D Molecular Therapeutics Jan 2022 - Present
    Emeryville, California, Us
  • 4D Molecular Therapeutics
    Vice President Technical Operations
    4D Molecular Therapeutics Jan 2021 - Mar 2022
    Emeryville, California, Us
    Functions:-Clinical Manufacturing and Supply Chain-Process Development-Analytical Development-Clinical QC-CMC Project Management
  • 4D Molecular Therapeutics
    Vice President, Process And Analytical Developmen
    4D Molecular Therapeutics Jan 2019 - Jan 2021
    Emeryville, California, Us
  • 4D Molecular Therapeutics
    Director, Process Sciences And Analytical Development
    4D Molecular Therapeutics Jun 2017 - Jan 2019
    Emeryville, California, Us
    Director of Process Development (upstream, downstream, and analytical) for gene therapy (AAV) products. Responsible for team engaged in key IND-enabling process development studies, including DOE-based optimization of upstream and downstream unit operations (cell expansion, transfection, harvest, clarification, column chromatography, TFF) and development, qualification, and transfer of IND-enabling assays (purity, potency, safety, identity)
  • Grifols Diagnostic Solutions
    Analytical Group Leader
    Grifols Diagnostic Solutions Aug 2014 - Jun 2017
    Sant Cugat Del Vallès, Barcelona, Es
    Analytical Group LeaderSubject Matter Expert in Analytical Methods Duties include:-Management of group of 6-8 associates performing analytical testing in support of small scale work-Directing assay development/improvement projects-Support QC validation/re-validation, assay improvements, and new assay implementations. -Lead and assist in investigations relating to Manufacturing or QC deviations and Out of Specifications (OOSs) and develop studies to determine their root causes. Identify and implement appropriate CAPAs. -Support process and product characterization, validation, and continuous verification, and cleaning validation studies. Support assay and process transfers.-Author technical documents including reports, protocols, product impact investigations, risk assessments, change controls, and deviation reports.
  • Baxter International Inc.
    Research Scientist Ii
    Baxter International Inc. Aug 2012 - Aug 2014
    Deerfield, Illinois, Us
    Research scientist II in the Process Analytical Development group, (Promoted from Research Scientist I Sept 2013. Interim Acting Manager of Analytical Group from March-July, 2014). -Assay development, qualification, and QC transfer for protein therapeutics -HPLC, UPLC, ELISA, Mass Spec, Glycan assays -degradation and stability studies -protein analytics and micro-heterogeneity assays-Analytical SME for multiple projects-OOS and OOT investigations-Worked in a GLP/GMP environment -Led a team of 3 research associates-Worked closely with quality, validation, regulatory, and QC groups-Authored sections of IND and BLA submissions (3.2.S. sections, including Elucididation of Structure and Other Characteristics, Impurities, Analytical Procedures, Specifications, and Control of Materials Sections). -Led and participated in FMEAs and risk assessments. Authored multiple technical documents (Memos, Technical Reports, Assay Qualification Reports, Comparability and Stability protocols and reports)
  • Dophen Biomedical
    Temporary Research Scientist
    Dophen Biomedical Jun 2012 - Aug 2012
    Developed bioanalytical assays for modified recombinant proteins-Generated and characterized protein conjugation products-Developed MALDI and LC-MALDI assays to determine the selectivity of PEG-modified proteins-Provided mass spec and analytical support for protein purification-Trained others in the use of MALDI for protein characterization
  • Catalyst Biosciences
    Staff Scientist I
    Catalyst Biosciences Aug 2011 - May 2012
    South San Francisco, Ca, Us
    Provided bioanalytical and mass spectrometry support for Protein Science and Assay Development groups. Designed and implemented analytical assays for recombinant proteins. Developed novel degradomics capabilities.-Implemented new N-glycan assays which reduced turnaround time from one week to three hours while increasing sensitivity and reproducibility and reducing sample requirements. Allowed protein quality to be quickly assessed prior to in vivo studies, leading to an increase in screening efficiency.-Designed novel isotope and chemical labeling techniques for monitoring protease selectivity (degradomics). Improved characterization of therapeutic protease candidates in purified and complex systems, giving essential information for future design rounds.-Analyzed recombinant protein quality (sequence, N- and O-glycan identity, site occupancy and sialic acid content, proteolytic processing, and post-translational modification) and correlated this information with plasmid design, allowing optimization of therapeutic candidates.
  • University Of California, Berkeley
    Postdoctoral Fellow
    University Of California, Berkeley Jul 2008 - Aug 2011
    Berkeley, Ca, Us
    Postdoctoral Fellow of the American Cancer Society, in the laboratory of Michael A. Marletta. Working on elucidating mechanisms of specificity of S-nitrosation.-Developed a mass-spec based method allowing the first kinetic measurements of nitrosation on whole proteins, leading to rate data for nitrosation of specific cysteines on a protein involved in cellular nitrosation.-Performed proteomics experiments that provided strong evidence for cellular signaling via transnitrosation.-Coordinated a two-lab, bicoastal collaboration (Steve Tannenbaum lab, MIT) leading to peer-reviewed publications.
  • The Scripps Research Institute
    Graduate Student
    The Scripps Research Institute Sep 2002 - Jun 2008
    La Jolla, California, Us
    Graduate student in the laboratory of Benjamin Cravatt, department of Chemical Physiology, working to expand proteome coverage of activity-based protein profiling technologies and their application to enzyme annotation.-Designed, synthesized, and utilized new classes of activity-based chemical probes for proteomics, and used these probes to discover novel biomarkers for obesity and diabetes.-Utilized chemical proteomics for substrate discovery in uncharacterized enzymes. Used molecular docking studies and mutagenesis for confirmation.-Produced protein crystals leading to the first structure of a mammalian nitrilase enzyme (1.4 Å resolution).

Katy Barglow Skills

Protein Chemistry Protein Purification Biochemistry Proteomics Hplc Mass Spectrometry Molecular Biology Cell Culture Assay Development Cell Cell Signaling Western Blotting

Katy Barglow Education Details

  • Scripps Research
    Scripps Research
    Biochemistry
  • University Of California, Berkeley
    University Of California, Berkeley
    Postdoctoral Fellow
  • Stanford University
    Stanford University
    Chemistry

Frequently Asked Questions about Katy Barglow

What company does Katy Barglow work for?

Katy Barglow works for 4d Molecular Therapeutics

What is Katy Barglow's role at the current company?

Katy Barglow's current role is SVP Technical Operations at 4D Molecular Therapeutics.

What is Katy Barglow's email address?

Katy Barglow's email address is ka****@****ols.com

What is Katy Barglow's direct phone number?

Katy Barglow's direct phone number is +151067*****

What schools did Katy Barglow attend?

Katy Barglow attended Scripps Research, University Of California, Berkeley, Stanford University.

What are some of Katy Barglow's interests?

Katy Barglow has interest in Biochemistry, Protein Analytics, Mass Spectrometry, Cell Biology, Enzymology, Cancer Biology.

What skills is Katy Barglow known for?

Katy Barglow has skills like Protein Chemistry, Protein Purification, Biochemistry, Proteomics, Hplc, Mass Spectrometry, Molecular Biology, Cell Culture, Assay Development, Cell, Cell Signaling, Western Blotting.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.